本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viking Therapeutics, Inc.

30.31
+0.36001.20%
成交量:143.41萬
成交額:4,334.10萬
市值:35.36億
市盈率:-6.49
高:30.77
開:30.02
低:29.80
收:29.95
52周最高:43.15
52周最低:22.96
股本:1.17億
流通股本:1.10億
量比:0.97
換手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-4.6676
每股收益(LYR):-3.1920
淨資產收益率:-88.85%
總資產收益率:-51.86%
市淨率:8.66
市盈率(LYR):-9.50

資料載入中...

2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/25

重要事件披露

Form 8-K - Current report
2023/07/27

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/26

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report